
BlossomHill Therapeutics: A biopharma firm innovating in oncology and autoimmune disorder treatments.
BlossomHill Therapeutics, Inc. was founded with the mission to address urgent unmet medical needs in oncology and autoimmune disorders. The company leverages a deep understanding of science, creative thinking, and extensive experience in drug design and development to create innovative small molecule therapies. Their core vision is to transform the treatment landscape for patients suffering from these serious conditions by providing effective and accessible solutions.
BlossomHill Therapeutics has attracted notable figures in the biopharmaceutical industry and secured investments from leading venture capital firms. The company has achieved significant milestones in drug discovery and development, demonstrating promising preclinical results. Its impact is marked by its potential to revolutionize treatment protocols and improve patient outcomes in the fields of cancer and autoimmune diseases.

Bayhill Therapeutics

Synnovation Therapeutics
synnovationtx.com

Thetis Pharmaceuticals
thetispharma.com

Allorion Therapeutics
alloriontx.com

Eikon Therapeutics
eikontx.com

Lapix Therapeutics
lapix.com

858 Therapeutics
8five8tx.com

Aristea Therapeutics

PineTree Therapeutics
pinetreetx.com

Deep Apple Therapeutics
deepappletx.com

Vesalius Therapeutics
vesaliustx.com

Rise Therapeutics

Vivace Therapeutics

Equillium
equilliumbio.com

Phanes Therapeutics
phanesthera.com
Companies similar to BlossomHill Therapeutics include Bayhill Therapeutics, Synnovation Therapeutics, Thetis Pharmaceuticals and Allorion Therapeutics.
BlossomHill Therapeutics was founded in 2020.
BlossomHill Therapeutics' headquarters is located in San Diego, CA, US.
BlossomHill Therapeutics' most recent funding round was for $88.6M (USD) in January 2024.
As of Jan 2, 2024, BlossomHill Therapeutics has raised a total of $161.6M (USD).
BlossomHill Therapeutics has 22 employees as of Feb 5, 2024.